Eurand : Launch of OTC Unisom SleepMelts by Chattem

April 29, 2008 – Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that Chattem, Inc. (“Chattem”) has launched a new orally disintegrating tablet (“ODT”) formulation of its popular over-the-counter (OTC) sleep-aid brand, Unisom^®.

Unisom^® SleepMelts^TM, which contains 25mg of diphenhydramine hydrochloride, was developed by Eurand using its AdvaTab^® and Microcaps^® taste-masking technologies. The product was developed as part of the EUR-1047 program. Unisom^® SleepMelts^TM, an OTC sleep-aid, is now available in leading U.S. mass merchandiser, drug and food retailers. Eurand will exclusively supply the product for Chattem, which will be manufactured at Eurand’s U.S. facility in Vandalia, OH... – Eurand's Press Release -